Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Caregaro

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Minerva Medica|July 21, 1978
[Acid-base metabolism in patients with hepatic cirrhosis treated with portacaval anastomosis at various intervals after the operation]G Conte, A Semplicini, L Caregaro, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Renal effects of nadolol in cirrhosisA Gatta, D Sacerdoti, C Merkel, et al.
Archives of Internal Medicine|April 1, 1991
Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trialP Angeli, M Chiesa, L Caregaro, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1987
Tubular handling of sodium and phosphate in non-ascitic liver cirrhosisL Caregaro, P Angeli, A Merlo, et al.
Journal of Hepatology|April 16, 1998
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosisL Caregaro, F Alberino, P Amodio, et al.
Journal of Hepatology|July 1, 1989
Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosisC Merkel, M Bolognesi, G F Finucci, et al.
Hepatology (Baltimore, Md.)|December 1, 1992
Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implicationsP Angeli, L Caregaro, F Menon, et al.
Digestion|January 1, 1987
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trialA Gatta, C Merkel, D Sacerdoti, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 16, 2001
Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disordersL Caregaro, A Favaro, P Santonastaso, et al.
Archives of Internal Medicine|January 24, 1994
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosisL Caregaro, F Menon, P Angeli, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Minerva Medica|July 21, 1978
[Acid-base metabolism in patients with hepatic cirrhosis treated with portacaval anastomosis at various intervals after the operation]G Conte, A Semplicini, L Caregaro, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Renal effects of nadolol in cirrhosisA Gatta, D Sacerdoti, C Merkel, et al.
Archives of Internal Medicine|April 1, 1991
Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trialP Angeli, M Chiesa, L Caregaro, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1987
Tubular handling of sodium and phosphate in non-ascitic liver cirrhosisL Caregaro, P Angeli, A Merlo, et al.
Journal of Hepatology|April 16, 1998
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosisL Caregaro, F Alberino, P Amodio, et al.
Journal of Hepatology|July 1, 1989
Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosisC Merkel, M Bolognesi, G F Finucci, et al.
Hepatology (Baltimore, Md.)|December 1, 1992
Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implicationsP Angeli, L Caregaro, F Menon, et al.
Digestion|January 1, 1987
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trialA Gatta, C Merkel, D Sacerdoti, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 16, 2001
Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disordersL Caregaro, A Favaro, P Santonastaso, et al.
Archives of Internal Medicine|January 24, 1994
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosisL Caregaro, F Menon, P Angeli, et al.
Pageof 5